Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mahamaya LifesciencesBOM:544611 +2.06%17 3-Year ROIIC % is 9.67 as of Mar. 2026, which is 30% below its 10-year median of 13.73. GuruFocus rates BOM:544611 with a GF Score™ of 17/100. The stock has 4 warning signs investors should review. Among 251 Agriculture companies, Mahamaya Lifesciences ranks better than 68.13% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Mahamaya Lifesciences's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 9.67%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Mahamaya Lifesciences's 3-Year ROIIC % or its related term are showing as below:
BOM:544611's 3-Year ROIIC % is ranked better than 68.13% of 251
companies
in the Agriculture industry
Industry Median: -1.47
vs BOM:544611: 9.67
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Mahamaya Lifesciences 3-Year ROIIC % Related Terms
Mahamaya Lifesciences 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Mahamaya Lifesciences's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544611 vs CTVA, CF, MOS: 3-Year ROIIC % Comparison
For the Agricultural Inputs subindustry, Mahamaya Lifesciences's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mahamaya Lifesciences 3-Year ROIIC % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Mahamaya Lifesciences's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Mahamaya Lifesciences's 3-Year ROIIC % falls into.
Mahamaya Lifesciences's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 216.391168 (Mar. 2026) - 60.8488 (Mar. 2023) )
/
( 2064.398 (Mar. 2026) - 455.31 (Mar. 2023) )
=
155.542368
/
1609.088
=
9.67%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Mahamaya Lifesciences (BOM:544611) has a 3-Year ROIIC % of 9.67 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Mahamaya Lifesciences and its competitors. This is 30% below median its historical median of 13.73. Over the past decade, Mahamaya Lifesciences' 3-Year ROIIC % has ranged from 9.67 to 17.79. According to the industry distribution chart, Mahamaya Lifesciences ranks #80 out of 251 companies in the Agriculture industry, placing it in the top 31.9%.
Is Mahamaya Lifesciences' 3-Year ROIIC % too high?
Mahamaya Lifesciences' current 3-Year ROIIC % of 9.67 is 30% below median its 10-year median of 13.73. Over the past 10 years, this metric has ranged from a low of 9.67 to a high of 17.79. Based on the distribution chart, Mahamaya Lifesciences ranks #80 out of 251 companies in the Agriculture industry, which is above the industry midpoint. Overall, Mahamaya Lifesciences has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' 3-Year ROIIC % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Mahamaya Lifesciences ranks #80 out of 251 companies for 3-Year ROIIC %. This puts Mahamaya Lifesciences in the upper half of its industry. Historically, Mahamaya Lifesciences' own 3-Year ROIIC % has ranged from 9.67 to 17.79 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for an Agriculture company?
A good 3-Year ROIIC % depends on the Agriculture industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Mahamaya Lifesciences and its competitors. Mahamaya Lifesciences's current 3-Year ROIIC % is 9.67, which is 30% below median its own 10-year median of 13.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current 3-Year ROIIC % of 9.67. The current 3-Year ROIIC % is 9.67, which is 30% below median its 10-year median of 13.73. Mahamaya Lifesciences' overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current 3-Year ROIIC % is 9.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
17GF Score
Get the complete analysis for BOM:544611
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544611 has been successfully added to your 
